Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

Josef Coresh, Brad C. Astor, Tom Greene, Garabed Eknoyan, Andrew S. Levey

Research output: Contribution to journalArticle

Abstract

Background: Recently developed clinical practice guidelines and calibration of the Third National Health and Nutrition Examination Survey (NHANES III) serum creatinine assay provide a basis for estimating the prevalence and distribution of chronic kidney disease (CKD) in the United States using standardized criteria based on estimated glomerular filtration rate (GFR) and persistent albuminuria. Methods:A nationally representative sample of 15,625 noninstitutionalized adults aged 20 years and older from the NHANES III was analyzed. Kidney function (GFR), kidney damage (albuminuria), and stages of CKD (GFR and albuminuria) were estimated from calibrated serum creatinine level, spot urine albumin level, age, sex, and race. GFR was estimated using the simplified Modification of Diet in Renal Disease Study equation and compared with the Cockcroft-Gault equation for creatinine clearance (CCr). Results: The prevalence of CKD in the US adult population was 11% (19.2 million). By stage, an estimated 5.9 million individuals (3.3%) had stage 1 (persistent albuminuria with a normal GFR), 5.3 million (3.0%) had stage 2 (persistent albuminuria with a GFR of 60 to 89 mL/min/1.73 m2), 7.6 million (4.3%) had stage 3 (GFR, 30 to 59 mL/min/1.73 m2), 400,000 individuals (0.2%) had stage 4 (GFR, 15 to 29 mL/min/1.73 m2), and 300,000 individuals (0.2%) had stage 5, or kidney failure. Aside from hypertension and diabetes, age is a key predictor of CKD, and 11% of individuals older than 65 years without hypertension or diabetes had stage 3 or worse CKD. Compared with GFR estimates, CCr estimates showed a steeper decline with age and were lower in non-Hispanic blacks. Conclusion: CKD is common and warrants improved detection and classification using standardized criteria to improve outcomes.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalAmerican Journal of Kidney Diseases
Volume41
Issue number1
StatePublished - Jan 1 2003

Fingerprint

Nutrition Surveys
Glomerular Filtration Rate
Chronic Renal Insufficiency
Albuminuria
Kidney
Population
Creatinine
Hypertension
Diet Therapy
Serum
Practice Guidelines
Calibration
Renal Insufficiency
Albumins
Urine

Keywords

  • Chronic kidney disease (CKD)
  • Clinical practice guidelines
  • Cockcroft-Gault equation
  • Glomerular filtration rate (GFR)
  • Modification of Diet in Renal Disease (MDRD) Study equation
  • National survey
  • Prevalence
  • US population

ASJC Scopus subject areas

  • Nephrology

Cite this

Prevalence of chronic kidney disease and decreased kidney function in the adult US population : Third National Health and Nutrition Examination Survey. / Coresh, Josef; Astor, Brad C.; Greene, Tom; Eknoyan, Garabed; Levey, Andrew S.

In: American Journal of Kidney Diseases, Vol. 41, No. 1, 01.01.2003, p. 1-12.

Research output: Contribution to journalArticle

@article{7f89f05ffb894dd099572b8f08124fb8,
title = "Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey",
abstract = "Background: Recently developed clinical practice guidelines and calibration of the Third National Health and Nutrition Examination Survey (NHANES III) serum creatinine assay provide a basis for estimating the prevalence and distribution of chronic kidney disease (CKD) in the United States using standardized criteria based on estimated glomerular filtration rate (GFR) and persistent albuminuria. Methods:A nationally representative sample of 15,625 noninstitutionalized adults aged 20 years and older from the NHANES III was analyzed. Kidney function (GFR), kidney damage (albuminuria), and stages of CKD (GFR and albuminuria) were estimated from calibrated serum creatinine level, spot urine albumin level, age, sex, and race. GFR was estimated using the simplified Modification of Diet in Renal Disease Study equation and compared with the Cockcroft-Gault equation for creatinine clearance (CCr). Results: The prevalence of CKD in the US adult population was 11{\%} (19.2 million). By stage, an estimated 5.9 million individuals (3.3{\%}) had stage 1 (persistent albuminuria with a normal GFR), 5.3 million (3.0{\%}) had stage 2 (persistent albuminuria with a GFR of 60 to 89 mL/min/1.73 m2), 7.6 million (4.3{\%}) had stage 3 (GFR, 30 to 59 mL/min/1.73 m2), 400,000 individuals (0.2{\%}) had stage 4 (GFR, 15 to 29 mL/min/1.73 m2), and 300,000 individuals (0.2{\%}) had stage 5, or kidney failure. Aside from hypertension and diabetes, age is a key predictor of CKD, and 11{\%} of individuals older than 65 years without hypertension or diabetes had stage 3 or worse CKD. Compared with GFR estimates, CCr estimates showed a steeper decline with age and were lower in non-Hispanic blacks. Conclusion: CKD is common and warrants improved detection and classification using standardized criteria to improve outcomes.",
keywords = "Chronic kidney disease (CKD), Clinical practice guidelines, Cockcroft-Gault equation, Glomerular filtration rate (GFR), Modification of Diet in Renal Disease (MDRD) Study equation, National survey, Prevalence, US population",
author = "Josef Coresh and Astor, {Brad C.} and Tom Greene and Garabed Eknoyan and Levey, {Andrew S.}",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
volume = "41",
pages = "1--12",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Prevalence of chronic kidney disease and decreased kidney function in the adult US population

T2 - Third National Health and Nutrition Examination Survey

AU - Coresh, Josef

AU - Astor, Brad C.

AU - Greene, Tom

AU - Eknoyan, Garabed

AU - Levey, Andrew S.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Background: Recently developed clinical practice guidelines and calibration of the Third National Health and Nutrition Examination Survey (NHANES III) serum creatinine assay provide a basis for estimating the prevalence and distribution of chronic kidney disease (CKD) in the United States using standardized criteria based on estimated glomerular filtration rate (GFR) and persistent albuminuria. Methods:A nationally representative sample of 15,625 noninstitutionalized adults aged 20 years and older from the NHANES III was analyzed. Kidney function (GFR), kidney damage (albuminuria), and stages of CKD (GFR and albuminuria) were estimated from calibrated serum creatinine level, spot urine albumin level, age, sex, and race. GFR was estimated using the simplified Modification of Diet in Renal Disease Study equation and compared with the Cockcroft-Gault equation for creatinine clearance (CCr). Results: The prevalence of CKD in the US adult population was 11% (19.2 million). By stage, an estimated 5.9 million individuals (3.3%) had stage 1 (persistent albuminuria with a normal GFR), 5.3 million (3.0%) had stage 2 (persistent albuminuria with a GFR of 60 to 89 mL/min/1.73 m2), 7.6 million (4.3%) had stage 3 (GFR, 30 to 59 mL/min/1.73 m2), 400,000 individuals (0.2%) had stage 4 (GFR, 15 to 29 mL/min/1.73 m2), and 300,000 individuals (0.2%) had stage 5, or kidney failure. Aside from hypertension and diabetes, age is a key predictor of CKD, and 11% of individuals older than 65 years without hypertension or diabetes had stage 3 or worse CKD. Compared with GFR estimates, CCr estimates showed a steeper decline with age and were lower in non-Hispanic blacks. Conclusion: CKD is common and warrants improved detection and classification using standardized criteria to improve outcomes.

AB - Background: Recently developed clinical practice guidelines and calibration of the Third National Health and Nutrition Examination Survey (NHANES III) serum creatinine assay provide a basis for estimating the prevalence and distribution of chronic kidney disease (CKD) in the United States using standardized criteria based on estimated glomerular filtration rate (GFR) and persistent albuminuria. Methods:A nationally representative sample of 15,625 noninstitutionalized adults aged 20 years and older from the NHANES III was analyzed. Kidney function (GFR), kidney damage (albuminuria), and stages of CKD (GFR and albuminuria) were estimated from calibrated serum creatinine level, spot urine albumin level, age, sex, and race. GFR was estimated using the simplified Modification of Diet in Renal Disease Study equation and compared with the Cockcroft-Gault equation for creatinine clearance (CCr). Results: The prevalence of CKD in the US adult population was 11% (19.2 million). By stage, an estimated 5.9 million individuals (3.3%) had stage 1 (persistent albuminuria with a normal GFR), 5.3 million (3.0%) had stage 2 (persistent albuminuria with a GFR of 60 to 89 mL/min/1.73 m2), 7.6 million (4.3%) had stage 3 (GFR, 30 to 59 mL/min/1.73 m2), 400,000 individuals (0.2%) had stage 4 (GFR, 15 to 29 mL/min/1.73 m2), and 300,000 individuals (0.2%) had stage 5, or kidney failure. Aside from hypertension and diabetes, age is a key predictor of CKD, and 11% of individuals older than 65 years without hypertension or diabetes had stage 3 or worse CKD. Compared with GFR estimates, CCr estimates showed a steeper decline with age and were lower in non-Hispanic blacks. Conclusion: CKD is common and warrants improved detection and classification using standardized criteria to improve outcomes.

KW - Chronic kidney disease (CKD)

KW - Clinical practice guidelines

KW - Cockcroft-Gault equation

KW - Glomerular filtration rate (GFR)

KW - Modification of Diet in Renal Disease (MDRD) Study equation

KW - National survey

KW - Prevalence

KW - US population

UR - http://www.scopus.com/inward/record.url?scp=0037228105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037228105&partnerID=8YFLogxK

M3 - Article

C2 - 12500213

AN - SCOPUS:0037228105

VL - 41

SP - 1

EP - 12

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 1

ER -